CN1873410B - 一种在食管癌病人血清中检测肿瘤相关标志物的方法 - Google Patents
一种在食管癌病人血清中检测肿瘤相关标志物的方法 Download PDFInfo
- Publication number
- CN1873410B CN1873410B CN2005100753670A CN200510075367A CN1873410B CN 1873410 B CN1873410 B CN 1873410B CN 2005100753670 A CN2005100753670 A CN 2005100753670A CN 200510075367 A CN200510075367 A CN 200510075367A CN 1873410 B CN1873410 B CN 1873410B
- Authority
- CN
- China
- Prior art keywords
- tumour
- albumen
- cancer
- serum
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 73
- 210000002966 serum Anatomy 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 23
- 201000011510 cancer Diseases 0.000 title claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 47
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 46
- 238000000926 separation method Methods 0.000 claims abstract description 20
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims abstract description 17
- 208000017897 Carcinoma of esophagus Diseases 0.000 claims abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 11
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims abstract description 10
- 238000000132 electrospray ionisation Methods 0.000 claims abstract description 8
- 238000001114 immunoprecipitation Methods 0.000 claims abstract description 7
- 238000000534 ion trap mass spectrometry Methods 0.000 claims abstract description 7
- 102100036976 X-ray repair cross-complementing protein 6 Human genes 0.000 claims abstract description 6
- 101710124907 X-ray repair cross-complementing protein 6 Proteins 0.000 claims abstract description 6
- 230000008878 coupling Effects 0.000 claims abstract description 6
- 238000010168 coupling process Methods 0.000 claims abstract description 6
- 238000005859 coupling reaction Methods 0.000 claims abstract description 6
- 230000029087 digestion Effects 0.000 claims abstract description 5
- 238000000605 extraction Methods 0.000 claims abstract description 4
- 230000009182 swimming Effects 0.000 claims description 15
- 238000001962 electrophoresis Methods 0.000 claims description 9
- 230000036039 immunity Effects 0.000 claims description 6
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000003119 immunoblot Methods 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 201000005619 esophageal carcinoma Diseases 0.000 claims description 3
- 239000003292 glue Substances 0.000 claims description 3
- 238000004811 liquid chromatography Methods 0.000 claims description 3
- 210000005259 peripheral blood Anatomy 0.000 claims description 3
- 239000011886 peripheral blood Substances 0.000 claims description 3
- 230000002093 peripheral effect Effects 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000000523 sample Substances 0.000 abstract description 8
- 238000004007 reversed phase HPLC Methods 0.000 abstract description 6
- 238000010186 staining Methods 0.000 abstract description 6
- 239000000427 antigen Substances 0.000 abstract description 5
- 102000036639 antigens Human genes 0.000 abstract description 5
- 108091007433 antigens Proteins 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 210000004881 tumor cell Anatomy 0.000 abstract description 3
- 239000000090 biomarker Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 12
- 229920002684 Sepharose Polymers 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 6
- 101710120037 Toxin CcdB Proteins 0.000 description 5
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 210000000981 epithelium Anatomy 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000005040 ion trap Methods 0.000 description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000004885 tandem mass spectrometry Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 102000004243 Tubulin Human genes 0.000 description 2
- 108090000704 Tubulin Proteins 0.000 description 2
- MGSKVZWGBWPBTF-UHFFFAOYSA-N aebsf Chemical compound NCCC1=CC=C(S(F)(=O)=O)C=C1 MGSKVZWGBWPBTF-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 208000031448 Genomic Instability Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000009060 clear cell adenocarcinoma Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- BCVXHSPFUWZLGQ-UHFFFAOYSA-N mecn acetonitrile Chemical compound CC#N.CC#N BCVXHSPFUWZLGQ-UHFFFAOYSA-N 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000005748 tumor development Effects 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100753670A CN1873410B (zh) | 2005-06-16 | 2005-06-16 | 一种在食管癌病人血清中检测肿瘤相关标志物的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100753670A CN1873410B (zh) | 2005-06-16 | 2005-06-16 | 一种在食管癌病人血清中检测肿瘤相关标志物的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1873410A CN1873410A (zh) | 2006-12-06 |
CN1873410B true CN1873410B (zh) | 2011-11-30 |
Family
ID=37483940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005100753670A Expired - Fee Related CN1873410B (zh) | 2005-06-16 | 2005-06-16 | 一种在食管癌病人血清中检测肿瘤相关标志物的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1873410B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102251013A (zh) * | 2011-02-22 | 2011-11-23 | 北京市肿瘤防治研究所 | 一个识别肿瘤起始细胞的抗体和抗原及其应用 |
CN102692505A (zh) * | 2011-03-21 | 2012-09-26 | 中国医学科学院肿瘤研究所 | 一种改进的免疫共沉淀技术方法 |
CN104713969B (zh) * | 2015-04-01 | 2017-04-12 | 山东省肿瘤医院 | 一种食管癌初步筛查用血清代谢组学分析模型的构建方法 |
CN109239210B (zh) * | 2018-09-10 | 2019-11-19 | 哈尔滨工业大学 | 一种胰腺导管腺癌标志物及其筛选方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399298B1 (en) * | 1998-06-30 | 2002-06-04 | Sloan-Kettering Institute For Cancer Research | Ku70—related methods |
CN1580247A (zh) * | 2003-08-15 | 2005-02-16 | 上海中科生龙达生物技术(集团)有限公司 | 食管癌单克隆抗体及其放射性标记物和化学交联物、以及其用途 |
-
2005
- 2005-06-16 CN CN2005100753670A patent/CN1873410B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399298B1 (en) * | 1998-06-30 | 2002-06-04 | Sloan-Kettering Institute For Cancer Research | Ku70—related methods |
CN1580247A (zh) * | 2003-08-15 | 2005-02-16 | 上海中科生龙达生物技术(集团)有限公司 | 食管癌单克隆抗体及其放射性标记物和化学交联物、以及其用途 |
Non-Patent Citations (2)
Title |
---|
毛友生,等.食管癌肿瘤标志物研究进展.《世界华人消化杂志》.2002,第10卷(第11期),1321-1323. * |
王立顺,等.以双向凝胶电泳为基础的食管癌组织蛋白质组学分析新策略.《中国免疫学杂志》.2003,第19卷(第4期),228-231. * |
Also Published As
Publication number | Publication date |
---|---|
CN1873410A (zh) | 2006-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7109008B2 (ja) | 膵臓がんを検出するための方法および組成物 | |
Jou et al. | Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer | |
Dowling et al. | Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis | |
Jou et al. | Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages | |
JP5256284B2 (ja) | 肺癌早期発見のための血清バイオマーカー | |
CN102687011B (zh) | 癌症生物标志物及其应用 | |
JP2007333744A (ja) | 細胞内蛋白質抗原および血清中の特異的細胞内蛋白質抗原に対する抗体の存在を同定するための方法 | |
CN1873410B (zh) | 一种在食管癌病人血清中检测肿瘤相关标志物的方法 | |
US20120295288A1 (en) | Serological marker for detecting pancreatic cancer and a method for using the serological marker | |
CN109655608A (zh) | 一种用于骨肉瘤诊断的外泌体蛋白及其即时检测方法 | |
Farina et al. | Bile proteome in health and disease | |
JP2008014937A (ja) | 腫瘍マーカー及び癌疾病の罹患の識別方法 | |
US20090280512A1 (en) | Tumor marker for renal cancer and method for determination of occurrence of renal cancer | |
KR101311717B1 (ko) | 대장암 진단용 단백질 마커 멜라노트랜스페린 및 이에 대한 항체를 포함하는 대장암 진단 키트 | |
KR100710462B1 (ko) | 폐암 진단용 퍼옥시레독신-i자가항체 마커 및 이를 이용한진단키트 | |
KR101311718B1 (ko) | 대장암 진단용 단백질 마커 rpe-스폰딘 및 이에 대한 항체를 포함하는 대장암 진단 키트 | |
JP5211315B2 (ja) | 腫瘍マーカ、腫瘍診断キットおよび腫瘍マーカの測定方法 | |
JP5358808B2 (ja) | 腫瘍マーカー、腫瘍診断キット、腫瘍マーカーの測定方法および腫瘍診断方法 | |
US20040191841A1 (en) | Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum | |
WO2022091793A1 (ja) | 糞便由来タンパク質を用いた膵臓がんバイオマーカーの開発 | |
US8834878B1 (en) | Antigen-antibody cancer recognition system | |
CN106191022B (zh) | 一种肿瘤特异抗原及其应用 | |
Hong | Identification of CLP36 as a tumor antigen that induces an antibody response in pancreatic cancer | |
CN115015550A (zh) | 丝甘蛋白聚糖蛋白作为男性川崎病的特异性标志物的应用 | |
KR100696705B1 (ko) | 폐암 진단용 단백질 마커 퍼옥시레독신-i 및 이를 이용한진단키트 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TUMOR HOSPITAL, CHINESE MEDICAL ACADEMY Free format text: FORMER OWNER: TUMOUR INST., CHINA MEDICAL SCIENCE RESEARCH ACADEMY Effective date: 20150820 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150820 Address after: 100021 No. 17, South Lane, Beijing, Panjiayuan, Chaoyang District Patentee after: CANCER HOSPITAL, CHINESE ACEDEMY OF MEDICAL SCIENCES Address before: 100021 Beijing, Panjiayuan, South Lane, No. 17, No. Patentee before: CANCER INSTITUTE, CHINESE ACADEMY OF MEDICAL SCIENCES |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111130 |